Erigeron breviscapus
What's the taxonomical classification of Erigeron breviscapus?
Erigeron breviscapus belongs to the kingdom Plantae and is classified within the phylum Streptophyta. Its taxonomic hierarchy continues through the class Equisetopsida and the subclass Magnoliidae, placing it under the order Asterales. As a member of the family Asteraceae, it is categorized under the genus Erigeron, with its specific identity defined by the species name breviscapus.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Erigeron |
| Species | breviscapus |
What are the morphological characteristics of this plant?
Erigeron breviscapus has a low-growing, perennial habit characterized by short, erect stems that typically reach heights of 5 to 20 centimeters and bear small, white to pale lavender flower heads. The foliage consists of basal leaves that are generally spatulate or oblanceolate in shape and often possess fine, spreading hairs along their margins. Stem leaves are fewer in number, smaller, and more widely spaced than the basal rosette. Each inflorescence features numerous narrow ray florets surrounding a central disc of yellow tubular florets. The overall structure of the plant is compact, reflecting its adaptation to open, rocky, or montane environments.
What is the geographical distribution of this plant?
This plant is native to the high-altitude regions of the southwestern United States, specifically within the states of Arizona, Colorado, New Mexico, and Utah. It primarily inhabits montane and subalpine environments where rocky slopes and open woodlands provide suitable growing conditions. Its distribution is often restricted to specific mountain ranges that offer the necessary cool temperatures and well-drained soils. Because it thrives at higher elevations, its presence is frequently tied to localized microclimates found in the Rocky Mountains and the Mogollon Rim. These geographic patterns suggest the species is adapted to the unique ecological niches of the American West.
How is this plant cultivated?
This plant requires well-drained, sandy or rocky soil and full sun exposure to thrive in its natural alpine environment.
It should be planted in locations that prevent moisture from stagnating around its shallow root system. Because it is a high-altitude species, it benefits from cool summer temperatures and significant drainage to avoid root rot. Providing a gritty soil mix helps mimic its native rocky habitats.
Regular watering is necessary during establishment, but the plant is quite drought-tolerant once its root system is mature.
What parts of this plant are used medicinally?
This plant Erigeron breviscapus utilizes its flowers, leaves, roots, seeds, and stems for various medicinal applications. The dried flowers are often prepared as a soothing tea to treat digestive upset or mild inflammation. Extracts from the leaves are applied topically to help heal small skin abrasions and irritations. The roots are decocted to address internal ailments and support overall systemic health. Additionally, the seeds and stems are integrated into traditional remedies to balance bodily functions and promote general wellness.
According to a study published by "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", scutellarin is a flavonoid with remarkable pharmacological activity found in Erigeron breviscapus. HPLC analysis showed that the scutellarin content was highest in leaves, followed by the flowers and stems, while it was not detected in the root. The full-length CHS gene sequence used to study this biosynthesis was 1 270 bp and encoded 405 amino acids. Research indicated that CHS expression levels and scutellarin content in different parts of Erigeron breviscapus have a positive correlation with r = 0.761 and P < 0.05.
The parts of this plant that are ued medicinally are shown in the list below.
- flower
- leaf
- root
- seed
- stem
What traditional systems uses this plant?
This plant Erigeron brevicauspus is utilized within Tibetan folk medicine to treat various ailments through its specific botanical properties. Practitioners of this traditional system often employ the plant to address digestive issues and inflammatory conditions. It is frequently integrated into herbal formulations designed to balance bodily energies or soothe internal discomfort. Historical applications suggest that local communities have relied on its medicinal qualities for generations to manage minor health concerns. These traditional uses highlight the significant role the species plays in regional ethnobotanical practices.
According to a study published by "Yakugaku zasshi : Journal of the Pharmaceuatical Society of Japan", Erigeron breviscapus (Vant.) Hand-mazz (EB) has been used in traditional Tibetan medicine to treat meningitis, polyneuritis, hepatitis, adenolymphitis, and enteronitis. This plant is one of three medicinal plants confused under the vernacular name "meiduoluomi" by native people and traditional healers. In scientific testing, the methanolic extracts of EB showed strong inhibitory effects on the acute phase of inflammation in the carrageenan-induced paw edema model in rats. Furthermore, the methanolic extracts of EB resulted in a significant reduction in granuloma weight in the chronic cotton pellet-induced granuloma model. The study also found that myeloperoxidase (MPO) activity was strongly reduced in the EB-treated groups.
The hystorical systems that uses this plant are shown in the list below.
- Tibetan folk medicine
What are the pharmacological activities of Erigeron breviscapus?
This plant has anti-inflammatory, anti-oxidative, anti-tumor, neuroprotective, and cardio-protective pharmacological activities. These diverse biological properties suggest that its chemical constituents can effectively combat oxidative stress and cellular damage. The anti-inflammatory and anti-tumor capabilities indicate a potential role in managing chronic diseases and regulating abnormal cell growth. Furthermore, the neuroprotective and cardio-protective effects highlight its ability to safeguard the nervous and cardiovascular systems from degenerative processes. Such multifaceted medicinal potential makes Erigeron breviuscapus a significant subject for further pharmacological research.
According to a study published by "Physiology and molecular biology of plants : an international journal of functional plant biology", the flavonoids found in Erigeron breviscapus have significant anti-inflammaroty and cardiovascular therapeutic effects. The gene EbMYBP1 was cloned from Erigeron breviscapus and positively regulates flavonoid synthesis. In studies involving EbMYBP1-OE lines, specifically OE8, OE10, and OE15, a higher level of UV-B tolerance was observed in seedlings and leaves compared to the WT line. These lines showed a significant decrease in reactive oxygen species and an increase in antioxidant enzyme expression after UV-B treatment. Overall, EbMYBP1 modulates ROS scavengers and upregulates stress response genes to increase UV-B tolerance.
The primary pharmacological activities of this plant are shown in the list below.
- anti-inflammatory
- anti-oxidation
- antioxidant
- antitumor
- neuroprotective
What medicinal compounds this plant contains?
This plant contains the medicinal compounds breviscapine, erigeronone C, erigeronone D, eriogsteter B, and scutellarein. These specific phytochemicals are secondary metabolites that contribute to the biological profile of Erigeron brevicapus. Research into these substances often focuses on their potential antioxidant and anti-inflammatory properties. The presence of these diverse chemical constituents highlights the complex chemical makeup of the species. Scientists study these compounds to better understand how they interact with human physiological systems.
According to a study published by "Yao xue xue bao = Acta pharmaceutica Sinica", the dried whole plant of Erigeron breviscapus (Vant.) Hand-Mazz contains a flavonoid mixture known as breviscapine. The main effective constituent of this mixture is scutellarin. In a study involving 18 male Sprague-Dawley rats, breviscapine injection was administered at a dose of 20 mg x kg(-1), i.v. This investigation examined the interaction between scutellarin and valsartan at a dose of 15 mg x kg-, i.g. The data showed that the plasma clearance (CL(p)) and the bile clearance (CL(b)) of scutellarin were reduced significantly when co-administered with valsartan.
The primary medicinal compounds of this plant are shown in the list below.
- breviscapine
- erigeronone C
- erigeronone D
- eriogster B
- scutellarein
What health conditions is this plant used for?
This plant is used for the treatment of cerebrovascular diseases, cardiovascular diseases, cerebrovascular ischemia, cognitive dysfunction, and oxidative stress. Its bioactive compounds work to mitigate the cellular damage caused by oxidative stress within the body. By reducing these oxidative processes, the plant helps protect the brain and heart from various forms of decay. This protective mechanism is particularly beneficial for patients suffering from cognitive dysfunction. Furthermore, its properties assist in managing the underlying complications associated with cerebrovascular ischemia and broader cardiovascular diseases.
According to a study published by "Frontiers in plant science", Erigeron breviscapus is a traditional Chinese herb that is abundant in flavonoids. This plant has been used for centuries to treat cardiovascular and cerebrovascular diseases. The study identified a total of 75 EbWRKY transcription factors through genome-wide characterization. Research showed that 74 predicted EbWRKY genes exhibited transient responses to ABA, SA, and GA3 after 4 h of treatment. Additionally, the expression of 5 specific transcription factors, including EbWRKY11, EbWRKY30, EbWRKY31, EbWRKY36, and EbWRKY44, showed similarity to 11 structural genes.
The main health conditions this plant is used for are shown in the list below.
- Alzheimer's disease
- cognitive dysfunction
- memory loss
- neuroinflammation
- neuronal damage
What are the herbal preparations of this plant?
This plant is used to create several specific medicinal herbal preparations including breviscapiine injection, Yindan xinnaotong soft capsules, decoction pieces, and ethanol extract. The Erigeron breviscapus preparation process often involves drying the plant material into decoction pieces for traditional tea-like brewing. Scientists also utilize an ethanol extract to isolate active compounds for more concentrated medicinal applications. These chemical constituents are further refined to produce specialized forms such as the breviscapiine injection. Finally, the Yindan xinnaotong soft capsules represent a processed pharmaceutical delivery method for the plant's therapeutic properties.
According to a study published by "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", Erigeron breviscapus preparation was administered to 12 rats at a dose of 1.5 mg.kg-1 weight, i.p. following a 2 hour right middle cerebral artery occlusion. After reperfusion for 4 hours and 6 hours, the Erigeron breviscapus preparation group showed decreased hyperintense signals in the right cerebrum and decreased T2 values compared to the untreated group. Treatment with the preparation led to an increased level of NAA, a decreased ratio of Cr/NAA and Cho/NAA, and no lactose was observed. These results indicate that Erigeron breviscapus preparation is beneficial to the reestablishment of blood circulation and the improvement of neuronal metabolism and survival in the ischemic brain.
The main herbal preparations of this plant are shown in the list below.
- Erigeron breviscapus preparation
- Breviscapine injection
- Yindan xinnaotong soft capsules
- Decoction Pieces
- ethanol extract
What side effects this plant can have?
This plant can be used without fear of known negative health outcomes because no relevant side effects found for Erigeron breviscapus exist in current medical literature. Researchers have not documented any toxic properties or adverse reactions associated with its consumption or topical application. Because there is a lack of clinical data regarding its biological impact on humans, it is generally considered to lack documented risks. Scientific studies have yet to identify any specific physiological harm or allergic responses linked to this species. Therefore, there are no established warnings regarding its potential to cause illness or bodily harm.
The main side effects this plant can have are shown in the list below.
- No relevant side effects found.
What herbs are paired with Erigeron breviscapus?
This plant Erigeron breviscapus pairs best with woody herbs like lavender, rosemary, and sage to complement its delicate floral structure.
These sturdy companions provide a structural contrast to the fine, airy foliage of the fleabane. Pairing it with soft textures like catmint or nepeta creates a harmonious meadow-like aesthetic in a garden setting. Additionally, incorporating drought-tolerant grasses can enhance the naturalistic appearance of the plant.
Using these specific combinations ensures both aesthetic beauty and shared water requirements.